The goal of this study was to determine the mag nitude of "facilitated" amino acid transport across tumor and brain capillaries and to evaluate whether amino acid transporter expression is "upregulated" in tumor vessels compared to cap illaries in contralateral brain tissue. Aminocyclopentane car boxylic acid (ACPC), a non-metabolized [)4C]-labeled amino acid, and a reference molecule for passive vascular permeabil ity, [67Ga]-gallium-diethylenetriaminepentaacetic acid (Ga DTPA), were used in these studies. Two experimental rat glio mas were studied (C6 and RG2). Brain tissue was rapidly pro cessed for double label quantitative autoradiography 10 minutes after intravenous injection of ACPC and Ga-DTPA.
aI., 1985; Mosskin et aI., 1987) . With the exception of methionine and fluorotyrosine, there is little information available for other amino acids in human subjects with respect to the time course of uptake, the appearance of radiolabeled metabolites in blood and tissue, and the in corporation of label into protein. The interpretation and kinetic analysis of methionine (and most other amino acid) data is complicated by the rapid appearance of radio labeled metabolites in blood and tissue, and because the rate of metabolism varies widely between patients (Hatazawa, et aI., 1989; lshiwata, et aI., 1989) . We have proposed and used non-naturally occurring amino acids, such as a-aminoisobutyric acid (AlB) and l-aminocyclo pentane carboxylic acid (ACPC), for imaging brain tu mors (Blasberg et aI., 1981 (Blasberg et aI., , 1983a (Blasberg et aI., , 1983b (Blasberg et aI., , 1984 Uehara et aI., 1997) . These amino acids were chosen because they are nonisomeric at the a-carbon (do not exist in opticaIJy active forms) and are not metabolized nor in corporated into protein in mammals (NoaIJ et aI., 1957; Oxender and Christensen, 1963) . However, these amino acids are transported across brain and tumor cell mem branes by stereospecific carrier systems (for reviews, see Guidotti et aI., 1978; ShotweIJ et aI., 1983; Saier et aI., 1988) .
In previous studies we used AlB and single-label quantitative autoradiographic techniques (QAR) to im age and measure transport (K1) across brain and brain tumor blood vessels (Blasberg et aI., 1980 (Blasberg et aI., , 1981 (Blasberg et aI., , 1983a (Blasberg et aI., , 1984 . We considered the AlB transport measurements to reflect' 'passive" vascular permeability of the tumors, because the luminal surface of normal brain capillaries were known to be devoid of system "A" transporters (Betz and Goldstein, 1978) and AlB is predominately transported across cell membranes by the A system transporter (Oxender and Christensen, 1963; Chris tensen, 1990) . In this study we performed similar experi ments using [ 14 C]_ACPC and gallium-diethylenetriamine pentaacetic acid ([ 67 Ga]-DTPA). ACPC was selected be cause it has similar transport characteristics compared to methionine and is transported across ceIJ membranes by both the L and A transport systems. In contrast to me thionine, ACPC is not metabolized in mammals and the problems associated with imaging radiolabeled metabo lites are avoided. To obtain corresponding measurements of passive vascular permeability, the [ 67 Ga]-DTPA che late was selected as a reference molecule. Double-label QAR experiments could be performed with this pair of radiolabeled tracers (Uehara et aI., 1997) , and the high spatial resolution autoradiography permits direct com parisons between ACPC transport and passive vascular permeability as measured by Ga-DTP A in specific tumor regions defined by morphologic characteristics seen in the corresponding histologic image. Two different ex perimental brain tumors (C6 and RG2) are compared in the rat; the C6 (Benda et aI., 1968) and RG2 (Wechsler et aI., 1972) cell lines are of glial origin.
The primary objective of this study was to determine the magnitude of "facilitated" ACPC transport across tumor and brain capillaries, and to compare these mea surements in morphologically defined tumor regions. The secondary objective was to compare the ACPC Kl measurements (0 to 10 minutes) to our previously re ported 0-to 60-minute measurements of apparent dis tribution volume (Uehara et aI., 1997) in comparable groups of animals. This study reports convincing data which suggests that facilitated transport of ACPC is up regulated across C6 and RG2 glioma capillaries, and that 0-to 10-minute ACPC experiments yield tumor images similar to that observed in 60-minute experiments (Uehara et aI., 1997) .
METHODS AND MATERIALS

Cell culture
The C6 glioma cell line (Benda et aI., 1968) was obtained from the Memorial Sloan-Kettering Cancer Center tissue cul ture bank; and RG2 (Wechsler et aI., 1972) cells were provided by Daryl Bigner, Duke University. The C6 glioma cell line was grown as a monolayer in F-IO media with 17.5% fetal calf serum using T -150 flasks (Falcon; Becton Dickinson and Co., Lincoln Park, NJ). RG2 cells were grown as monolayers in minimal essential medium with 10% fetal calf serum and non essential amino acids in T -1 50 flasks. The cultures were main tained in an incubator with 5% CO 2 , 80% humidity at 37°C.
Cells were passaged each week or used for implantation after having become 90% confluent.
Tumor inoculation
Fifteen male rats weighing 230 to 270 g were studied: 7
Fisher 344 rats bearing RG2 gliomas, 8 Wi star-Furth rats bear ing C6 gliomas. The rats were anesthetized with the gas mix ture consisting of 5% of isoflurane, 65% of nitrous oxide, and 30% of oxygen and they were maintained with 1.5% isoflurane.
Two percent Lidocaine gel was applied to the ears and the head was fixed to a stereotactic apparatus. After a midline scalp incision, a 2-mm burr hole was made 3 mm lateral from the sagittal suture and I mm posterior from the coronal suture.
Then, stereotactically, a 25-gauge needle attached to a Hamil ton syringe was inserted to 6 mm depth from the dura mater and 5.0 x 105 tumor cells in 10 f.1L medium was injected into the right caudate nucleus over 5 minutes. After this procedure, the animals were placed in standard cages with normal feedings.
The experimental protocol was approved by the Institutional Animal Care and Use Committee. 
Isotope preparation
Animal preparation and study
Twelve days after tumor implantation, the animals were fasted for 12 hours followed by placement of femoral artery and vein catheters under gas anesthesia. The rats were immo bilized by wrapping them with a loosely fitting plaster bandage and allowed to recover from anesthesia for at least I hour before study (Sokoloff et aI., 1977 injected intravenously with a lethal dose of pentobarbital (1 50 mg/kg), decapitated, and a blood sample obtained. The brain was then rapidly extracted and frozen in liquid freon. The 10minute blood sample and a measured fraction of the total blood withdrawn during the experiment were processed for measure ments of whole blood and plasma radioactivity and hematocrit. The blood and plasma concentration-time integral (input function) was calculated as previously described (Gjedde, 1982) .
Radioactivity assay
All blood and plasma samples were solubilized (Soluene- Calculations Kl (f.LLiminig) of ACPC and Ga-OTPA was calculated from:
where A T is the total measured radioactivity (percent adminis tered dose per gram tissue) at the end of the experiment, V h is 1998 the tissue blood volume (mUg tissue); Cb T and C p T are the arterial blood and plasma concentrations (percent administered dose per milliliter blood or plasma) at the end of the experi ment; and f C / t) dt is the plasma concentration-time integral (input function). The values of Vb for tumor and brain were obtained from previous studies (Blasberg, et aI., 1983a; Nak agawa et aI., 1988) . f C p (t) dt was calculated from the measure ment of total radioactivity withdrawn during the experiment and knowledge of the rate of withdrawal and time of exposure (Gjedde, 1982) . To avoid significant tissue-to-blood backflux of tracer during the experimental period, the experimental time was kept short (5 or 10 minutes). The basis for determining Kl from 0-to lO-minute experiments has been established [Ohno et aI., 1978 , Blasberg et aI., 1983b , and represents an upper limit value.
To identify the facilitated component of ACPC transport across endothelial cells, aK1 ACPC , the measured value of Kl ACPC was corrected for passive diffusion through tumor en dothelial cell pores (as measured with Ga-OTPA) and for pas sive diffusion of ACPC across the lipid bilayer membranes of the endothelial cells using the following relationship:
Pore diffusion corrects for the difference in aqueous diffu sion between Ga-OTPA and ACPC; it assumes no difference in sterric restriction between these molecules due to pore size (unlikely for these small water soluble molecules [Nakagawa et aI., 1987] ):
where 0 ACPC/OGa -DT PA is approximately 1.9 and can be esti mated from the inverse ratio of the square roots of their mo lecular weights [(0 ACPC/OGa-DTPA) -(MW Ga_DT PA )1/21 (MW Acpdi/2 (Oavson and Oanielli, 1943) . Membrane diffu sion can be calculated by a relationship that includes lipid solubility and aqueous diffusion:
where the octanol/water partition coefficient is assumed to be a measure of lipid membrane solubility and 0 is the aqueous water diffusion constant at 37°C. This relationship was origi nally described by Oavson and Oanielli (1 943), and later modi fied (Fenstermacher, 1983; Fenstermacher and Rapoport, 1984) . The aqueous diffusion constant can be estimated from 0 -10-4 (Mw)ll2 cm 2 /sec (Oavson and Oanielli, 1943); 0 ACPC is -8.8 X 10-6 cm 2 /sec and 0Ga-DT PA is -4.6 X 10-6 cm 2 /sec. The octanol/water partition coefficients of ACPC and OTPA have been measured: 6.7 x 10-3 (Smith, et aI., 1987 ) and 1.3 ± 0.2
x 10-4 (Blasberg et aI., 1983c) , respectively. Membrane diffu sion for ACPC was calculated to be 1.9 f.LLimin/g using Eq. 4, and it was assumed to be the same for both tumor and brain blood vessels. Similarly, membrane diffusion for Ga-OTPA was calculated to be 0.01 9 f.LUmin/g and was considered to be negligible with respect to that of ACPC. Thus, aK1
ACPC can be calculated using Eq. 2 and is an approximation of the fa cilitated component of ACPC transport across brain and tumor capillaries.
Statistics
Comparisons between ROI mean values were analyzed by two statistical methods. A paired t-test was used for compari-sons within individual animals (e.g., between tumor and normal brain), and a non-paired t-test was applied for comparisons between different sets of animals. Significant differences were determined at P < .05.
RESULTS
The autoradiographic images were registered with the corresponding histology and specific ROJ were defined on morphologic criteria (tumor margin, intratumoral ar eas with comparatively high and low cell density, areas of impending necrosis, and areas of brain adjacent to tumor). Necrotic-appearing regions were very small or absent in most of the C6 and RG2 tumors, except for one large C6 tumor (Fig. I) . We separated the tumors into two different areas of the brain (cortical and subcortical), and our analysis of the data reflects this separation even when a single tumor occupies both brain areas. There were only a few meningeal extensions of the tumors in this series compared to that observed previously (Uehara et. aI, 1997 ). This regional separation of tumor measure ments was performed because the data and previous re sults indicated that the site and size of tumor growth can have a substantial effect on different physiologic mea-D surements, such as blood flow and vascular permeability (Blasberg, et aI., 1984) .
ACPC influx (K) across normal brain capillaries was >200-fold greater than that of Ga-DTPA (Table I) , and this difference was largely due to facilitated ACPC trans port (aK/ c P c ; Eq 2). Substantially higher K) values for ACPC compared to Ga-DTPA were also measured in C6 and RG2 gliomas. Of note is the substantially higher influx of ACPC across C6 tumor capillaries compared to contralateral brain capillaries, and this difference cannot be explained by differences in passive diffusion of ACPC through endothelial cell pores of tumor capillar ies, as measured by Ga-DTPA. Based on the calculation of aK) ACPC (Eq 2), facilitated ACPC transport across C6 glioma capillaries is substantially greater than that across cortical or corpus callosum capillaries. The differences in ACPC transport across RG2 glioma compared to contra lateral brain capillaries was marginal (significant only in comparison to corpus callosum). These differences are readily seen in the parametric images of ACPC and Ga DTPA influx (K) in C6 gliomas ( Fig. 1 A-C) , and less well visualized in RG2 gliomas ( Fig. 1 D-F ).
K) for ACPC was higher in high cell density regions
FIG. 1. Histology and autoradiographic comparisons. Coronal sections through the brain of two rats containing a large C6 glioma (A, B, and C) and moderate size RG2 glioma (0, E, and F) are shown. The corresponding histologic (A and D) and autoradiographic images (B and E, and C and F, respectively) were generated from the same tissue section. The tumors were outlined on the histologic image (red line) and the outline was transferred to the co registered autoradiographic images. The autoradiographic images are color-coded to the same range of K, ACPC (B and E) and K, Ga-DTPA (C and F) values. Note the central zone if ischemia/necrosis in the in the C6 glioma (pale staining area, A); this area has low ACPC transport (K,A c p C = 19.1 J,JUmin/g and aK, A c p c = 4.8 J,JUmin/g) and low vascular permeability to Ga-DTPA (K, Ga-DTPA = 6.5 J,JUmin/g). Note the tissue slicing artifacts through both tumor and brain in 0; there was some correspondence between high K, ACPC values and the increase in K, Ga-DTPA along the meningeal surface of this RG2 tumor. This localized increase in ACPC and Ga-DTPA K, along the meningeal portion of the tumor stands in contrast to the more commonly observed pattern,
where little or no difference in ACPC transport and vascular permeability to Ga-DTPA are observed between RG2 gliomas and normal brain (see the subcortical portion of the tumor). Also note the higher vascular permeability (Ga-DTPA) and facilitated transport (ACPC) in choroid plexus. 47.5 ± 17.5 (7) § 11 58.9 ± 21.2 (7) § 11
28.6 ± 12.1 (5) 11 24.7 ± 11.9 (7) 11 22.6 ± 8.1 (IS) 17.6 ± 6.8 (15) [67GaJ-OTPA K, (fLL/min per g) 2.3 ± 0.9 (7) § 11 3.2 ± 0.9 (7) § 11 0.09 ± 0.03 (5) 11 0.10 ± 0.05 (7) 11 0.09 ± 0.04 (15) 0.06 ± 0.03 (15) [14C]-ACPC ilK] (fLL/min per g)t 41.2 ± 16.9 (7) § 11 51.1 ± 21.8 (7) § 11 26.5 ± 12.1 (5) 11 22.6 ± 11.8 (7) 11 20.6 ± 8.1 (15) 15.6 ± 6.8 (15) ACPC. I-aminocyclopentane carboxylic acid; Ga-OTPA, gallium-diethylenetriaminepentaacetic acid.
* Vascular transport, expressed as an influx (plasma clearance) constant, Kl, was calculated from 10 minutes ACPC and Ga-OTPA experiments; values are the mean ± SO, the number of animals is given in parenthesis.
t ilK] was calculated from equation 2 and reflects "carrier-mediated" transport across the capillaries.
:j: The site of tumor growth was also considered in our analysis. There were eight animals with C6 gliomas (one animal's tumor was limited to cortex, and another animal's tumor was limited to the subcortex); there were seven animals with RG2 gliomas (two animals did not have a subcortical extension of the tumor).
§ Statistically significant value compared to the corresponding contralateral frontal cortex (P < 0.05, paired t-test).
II Statistically significant value compared to the corresponding contralateral corpus callosum (P < 0.05, paired t-test). and lower in low cell density regions of both C6 and RG2 gliomas; the morphologically identified region to mean tumor values are shown in Table 2 . The tumor macro scopic margins of C6 tumors were well defined by the ACPC autoradiograms in 12 of 14 cortical and subcor tical tumor areas when compared to the histology (Fig.  lA, 1B) . In contrast, the tumor margins were less distinct in RG2 gliomas, and could be accurately identified in only two of five cortical and two of seven subcortical tumor regions identified on histology. Pale-staining tu mor areas suggestive of impending tissue necrosis had values of K1 higher than the mean for both C6 and RG2 gliomas ( Table 2) .
The level of [14C]-ACPC and [67Ga]-Ga-DTPA ra dioactivity in tumor and brain tissue, expressed as a per cent of injected dose per gram of tissue at time of imag ing, is important for clinical imaging and is shown in Table 3 . The tumor-to-contralateral brain (cortex) ratio is frequently used in the clinical assessment of brain tu mors, and these ratios are shown in Table 4 . For C6 gliomas, the tumor-to-contralateral cortex radioactivity ratio ranged between 1.4 and 4.4 for ACPC and from 1.8 "High" cell density 1.25 ± 0.23 (7)+ 1.25 ± 0.23 (7)+ 1.15 ± 0.29 (7) "Low" cell density 0.82 ± 0.09 (7)+ 0.81 ± 0.09 (7):j: 0.79 ± 0.13 (7)+ "Impending" necrosis 1.35 ± 0.37 (5):j: 1.36 ± 0.38 (5)+ 1.52 ± 0.26 (5)+ ACPC, I-aminocyclopentane carboxylic acid; Ga-OTPA, gallium-diethylenetriaminepentaacetic acid.
* The tumor region to mean tumor ratio of measured radioactivity was calculated; values are the mean ± SO and the number of animals is given in parenthesis.
t ilK] was calculated for each tumor region and the entire tumor using equation 2, and the ratio is presented. + Statistically significant values (P < 0.05, paired t-test). and 5.2 for Ga-DTPA; for RG2 gliomas the correspond ing range of ratios was much less (0.76 to 1.7 for ACPC and 0.80 to 4.0 for Ga-DTPA, respectively).
DISCUSSION
Normal brain capillaries are devoid of the A (small neutral amino acid) transport system on the luminal por tion of their cell membranes, in contrast to the relatively high expression of the L (large neutral amino acid) trans porter on both luminal and abluminal surfaces (Betz and Goldstein, 1978) . This arrangement and polarity of amino acid transporters in normal brain capillaries may be somewhat different in brain tumor capillaries due to the disruption of the blood brain barrier and to the ex pression of vascular growth factors by the tumor (Gleadle and Ratcliffe, 1997) . Our in vivo results with ACPC do not clarify whether the polarity of the A trans porter is retained in tumor capillaries because ACPC accumulation could reflect bidirectional transport via the Na+-independent L transport system as well as transport by the Na+-dependent A transport system (Handlogten et aI., 1988; Christensen, 1990) .
Upregulation of ACPC transport across brain tumor capillaries
To assess the facilitated component of ACPC trans port, ilK] ACPC , across disrupted brain tumor capillaries, the measured (total) ACPC influx, Kt CPC , was cor rected for passive diffusion through tumor endothelial cell pores (as measured with Ga-DTPA) and for passive diffusion of ACPC across the lipid bilayer membranes of the endothelial cells using the relationship described by Equation 2. The relationship between the permeability of natural membranes and substrate lipid solubility was originally described by Davson and Danielli (1943) . This relationship has been slightly modified and tested for cerebral blood vessels (Fenstermacher, 1983; Fensterma cher and Rapoport, 1984) . More recently, Fenstermacher (1988) refined the relationship to eliminate or reduce the effects of carrier-mediated transport, rapid metabolism, and plasma protein binding. An extensive assessment of (5) 1.36 ± 0.49 (5) Subcortical tumor 1.11 ± 0.39 (7) 1.61 ± 1.12 (7) Peri tumoral brain:j:
1.06 ± 0.30 (7) 1.30 ± 0.34 (7) ACPC, l-aminocyclopentane carboxylic acid; Ga-OTPA, gallium diethylenetriaminepentaacetic.
* The mean tumor to contralateral frontal cortex concentration ratio was calculated; values are the mean ± SO, the number of animals is given in parenthesis.
t Statistically significant values (P < 0.05). :j: Brain region extending 100 to 200 /-Lm from the macroscopic bor der of the tumor.
the saturable and non saturable components of neutral amino acid flux across normal brain vessels has been performed by Smith et al (Smith, et aI., 1987; Smith and Takasato, 1987) . They showed that passive membrane diffusion (non saturable flux, Kd) for most neutral amino acids was small compared to the facilitated component of amino acid transport (saturable flux), even at normal plasma amino acid concentrations ( Table 5 ).
The K] values of DTPA and AlB in normal cortex have also been measured (2.1 ± 0.1 and 0.024 ± 0.001 f,LLlmin/g, respectively; Blasberg et aI., 1983a) , and can be compared to the values of membrane diffusion (1.0 and 0.019 f,LLlmin/g, respectively) calculated using Equation 4.* The similarity between the measured K] and calculated Kd(calc) values are consistent with the view that there are few or no pores in normal brain capillaries, little or no facilitated blood-to-brain transport of AlB across normal brain capillaries, and little or no expression of the A amino acid transporter on the lumi nal surface of normal brain capillaries. In the case of abnormal tumor vessels with increased vascular perme ability, Ga-DTPA provides a direct measure of passive vascular permeability and can be used in the calculation of ilK] ACPC (Eq 2). The calculation of ilKj ACPC was pos sible in these studies because double-label experiments were performed and measurements of K] ACPC ) and K] G a DTPA were determined from the same tissue sections in anatomically defined tissue regions using QAR and im-*Previously published octanol-water partition coefficients (Blasberg et aI., 19S3c) were used in this calculation. ACPC, I-aminocyclopentane carboxylic acid * PA, cerebrovascular permeability-surface area product, . t Kd, constant for nonsaturable transport, . :j: Kd(calc), "membrane diffusion" constant, calculated using equation 4 and octanol water partition coefficients presented in . § From Smith and Takasato (1987) : l! calculated from data presented in Smith and Takasato (1987) and ; 'IIcalculated from PA -Vmax/Km(app), Smith and Takasato (1987) and . ** From .
age registration techniques. Thus, ilK] ACPC is considered to be a better approximation of the facilitated component of ACPC movement across both tumor and normal brain capillaries than the measured value of K] ACPC . ACPC flux across C6 glioma vessels (K] ACPC ) was significantly (two-fold) higher than that of normal brain and this difference was largely (87%) due to an increase in facilitated transport (ilK/ c P c ), rather than to an in crease in passive vascular permeability. This difference in facilitated transport is probably related to an upregu lation of amino acid transporter expression and density in tumor endothelial cells (number of transporters per unit endothelial cell surface area) compared to that in cortex. Alternatively, a constitutive (functional) change in the amino acid transport systems of tumor endothelial cells has not been excluded by these studies and requires fur ther evaluation. A less likely explanation for the differ ences in ilK1 ACPC between tumor and contralateral brain is a higher capillary density and surface area in C6 glio mas compared to cortex, with little or no difference in endothelial cell transporter density. No measurements of capillary density or capillary surface area have been re ported for C6 gliomas.
Passive and facilitated ACPC flux were marginally higher in RG2 gliomas compared to that observed in contralateral brain when expressed in terms of tissue mass. However, measurements of RG2 brain tumor cap illary density and surface area have been shown to be substantially less than that of normal rat gray matter [Schlageter et aI., in press] . When ilK/ c PC values are normalized to capillary surface area, the ilK] ACPC -:-cap illary surface area ratio (proportional to vascular perme ability, P) is approximately two-fold higher in RG2 brain tumors (-2.9 x 10-4 cm/min) compared to that in normal rat cortex (-1.4 x 10--4 cm/min). This calculation sug gests that facilitated ACPC transport across RG2 tumor capillaries is also upregulated.
ACPC transport and morphologic characteristics of C6 and RG2 brain tumors
High and low cell density regions of both gliomas corresponded with high and low values of K] and J Cereb Blood Flow Metab, Vol. 18, No. 5, 1998 ilK/ CPC for ACPC, similar to the Va measurements re ported previously (Uehara, et aI., 1997) . A similar pat tern of vascular permeability (K] for DTPA) and tumor cell density was also noted. Pale staining areas that ap peared to reflect impending necrosis on histology were observed in the larger C6 gliomas and much less often in RG2 tumors. These morphologically identified regions were previously shown to accumulate fluorodeoxyglu cose to high levels (possibly related to enhanced glycol ysis and anerobic metabolism), whereas corresponding measurements of Va for ACPC and K1 for Ga-DTPA showed little or no difference from the mean tumor value (Uehara, et al. 1997) . In this study, K] values for both ACPC and Ga-DTPA were significantly increased in pale staining tumor regions. We have recently shown that the transport rate (K]) of ACPC into C6 tumor cells in culture is increased several-fold when the cells are trans ferred from normoxic (20% 02) to hypoxic (5% and 2% 02) incubation conditions [Sasajima, et aI., 1997 ]. These in vitro results and the in vivo results reported here sug gest that both tumor cells and endothelial cells have the capacity to upregulate the expression of amino acid transporters in their cell membranes under adverse envi ronmental conditions such as hypoxia and hyponutrician.
Passive vascular permeability
Passive vascular permeability measured with Ga DTPA, K1 G a -DTPA , was low in the C6 gliomas (2 to 3 lLL!min/g) and very low in the RG2 gliomas (0.1 ILL! min/g). This observation was somewhat surprising when compared to the K] values measured previously with AlB in C6 gliomas (Hiesiger et aI., 1986) and RG2 glio mas (Groothuis, et aI., 1983) , and to the K] values mea sured with radioiodinated albumin in RG2 gliomas [Na kagawa et aI., 1987] . K] for AlB was 16.0 ± 1.5 ILL! min/g and 37 ± 10 lLL!min/g in C6 and in RG2 gliomas, respectively; Kj for albumin was 2.36 ± 0.89 and 0.27 ± 0.19 lLL!min/g in large and small RG2 gliomas, respec tively. Radioiodinated albumin and AlB were considered to be markers of passive vascular permeability in these studies. In contrast to ACPC, AlB is primarily trans ported across cell membranes by the A system (Oxender and Christensen 1963) , and previous studies using AlB as a marker of brain tumor vascular permeability (Groothuis, et ai., 1983; Blasberg et ai., 1983d Blasberg et ai., , 1984 Hiesiger et ai., 1986 ) assumed a polarity of the A trans port system in tumor vessels similar to that described in normal brain vessels (Betz and Goldstein, 1978) .
The differences between K j G a -DTPA measured here and K j AIB measured previously in RG2 (Groothuis, et ai., 1983) and C6 (Hiesiger et ai., 1986) gliomas are difficult to resolve and may reflect changes in phenotype (passive vascular permeability) of the tumors that oc curred during maintenance of these cell lines over a pe riod of 10 or more years. This interpretation is supported by the substantial difference between K j G a -DTPA reported here and K j a lb u m i n reported previously for RG2 gliomas (Nakagawa et ai., 1987) . In addition, the previously re ported values of K l AIB and K j a jb u mi n for RG2 gliomas are consistent with the large interendothelial cell gaps in RG2 tumor vessels (Schlageter et ai., in press ). Namely, the magnitude of the interendothelial cell gaps (1.1 x 10 -4 cm 2 /g tumor) and the magnitude of Kt IB and K j a lb u m i n in RG2 gliomas is consistent with passive diffusion of both AlB and albumin through endothelial cell pores.
Imaging brain tumors with radio labeled amino acids
Animal experiments indicate that ACPC has better blood-brain barrier (BBB) transport characteristics for imaging tumors than methionine, although methionine is the amino acid currently being used in most nuclear medicine brain tumor imaging studies. Brain uptake in dex (Pardridge, 1977) and in situ brain perfusion (Smith and Takasato, 1987; Smith, et ai., 1987) studies have shown that brain capillaries have a higher maximum transport rate (Vmax) for ACPC than methionine; Vmax for ACPC transport across normal brain capillaries is approximately twice that of methionine and similar to leucine (Table 5 ). In contrast, the affinity of methionine (and other large neutral amino acids) for the L trans porter across the BBB is considerably greater (lower Km) than that of ACPC. The apparent Km [Km ( app ) ] for amino acid transport across the BBB at physiologic (plasma) amino acid concentrations is some 10-to 20-fold greater than in the absence of plasma amino acids (Smith, et ai., 1987 ; Table 5 ). One consequence of high affinity for the L transporter is that the endothelial transport system is nearly saturated under normal physiologic conditions (-96%; Smith, et ai., 1987) . Another point is that Km ( app ) for ACPC is also considerably greater than Km ( app ) for methionine and other large neutral amino acids (Table 5) , and is greater than the summed plasma concentration (-1.0 J..L mol/mL) of high affinity (C/Km � 1) neutral amino acids (Smith, et ai., 1987) . Therefore, ACPC transport will be less affected by fluctuations in plasma amino acids levels than methionine or leucine. As de-scribed by Smith and Takasato (1987) , a five-fold in crease or decrease in total plasma amino acid concentra tion will result in only a small change in the net transport rate of amino acid flux across the BBB; they estimate this change to be less than 15%.
Amino acid competition studies in tissue culture and in tissue slices have shown that ACPC has a higher af finity for the A transport system of tumor and brain cell membranes than methionine (Oxender and Christensen, 1963; Blasberg, 1968; Christensen, 1990) . This differ ence in affinity for the A transport system is likely to result in a higher uptake of ACPC than methionine in tumor tissue because the A transporter is more highly expressed in transformed and malignant cells (Foster and Pardee, 1969; Isselbacher, 1972; Saier et ai., 1982; Handlogten and Kilberg, 1988) . These observations in tissue culture and animals are important because the higher affinity for the A carrier system in tumor cell membranes and the higher Vmax across endothelial cells provide the physiologic basis for imaging brain tumors with ACPC rather than with methionine or other amino acids. The absence of radiolabeled metabolites with ACPC is an additional advantage; 60 minutes after in travenous administration of [11C]-methionine, only 37% (range, 16 to 72%) of measured plasma radioactivity is parent methionine (Hatazawa et ai., 1989; Ishiwata et ai., 1989) , and a corresponding variability of radiolabeled metabolites in tumor tissue could confound interpretation of the images.
Despite the advantages of ACPC compared to methi onine described above, [ ll C]-methionine remains the ra diolabeled amino acid most frequently used to image brain tumors. The incorporation of [ ll C]-amino acids into tumor protein is a frequently cited rationale for im aging tumors with methionine and other amino acids.
However, this interpretation of e l C]-methionine tumor images is based largely on the results of animal studies (there have been no direct tissue assays in human sub jects measuring or documenting incorporation of radio activity into tumor protein). Contrary to some points of view, amino acid transport may be more important for tumor imaging in patients than amino acid incorporation into protein. This controversial suggestion is based on the results of several dynamic positron emission tomog raphy studies using methionine (Roelcke et ai., 1996) , fluorophenyla1anine (Miura et ai., 1989; Ito et ai., 1995) , and fluorotyrosine (Wienhard, et ai., 1991) . These results suggest that the incorporation of radiolabeled amino ac ids (such as methionine) into brain and tumor protein is small, and not likely to substantially contribute to the tumor images in patient studies.
CONCLUSION
Our results suggest that facilitated transport of ACPC is upregulated across C6 and RG2 glioma capillaries. This represents a new observation and suggests that tu mors can influence transporter expression in their sup porting vasculature. However, the results do not define which amino acid transporter (e.g., A or L) is upregu lated. Nevertheless, these initial results are a first step in furthering our understanding of functional changes that occur in brain tumor vasculature, and the potential sig nificance of these changes for clinical imaging of brain tumors using radiolabeled amino acids.
